Phaos Technology Holdings (Cayman) (POAS) Work In Process (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Work In Process of $39665.2 for Q2 2025, up 122.8% year-on-year from $17803.2 in Q2 2024, and up 122.8% on a QoQ basis from $17803.2 in Q2 2024.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Work In Process data on file, last reported at $39665.2 in Q2 2025.
- For the quarter ending Q2 2025, Work In Process rose 122.8% year-over-year to $39665.2; the trailing twelve-month figure through Apr 2025 stood at $39665.2 (up 122.8% YoY), and the FY2025 full-year result was $40614.0, up 128.13% from the prior year.
- Work In Process for Q2 2025 stood at $39665.2, up from $17803.2 in the prior quarter.
- Across five years, Work In Process topped out at $39665.2 in Q2 2025 and bottomed at $17803.2 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 39,665.18 |
| Apr 30, 2024 | 17,803.24 |